Healthy adults
Conditions
Interventions
Participants smell the aroma of the test product and then ingest the 150mL volume.
Participants smell the aroma of the control product and then ingest the 150mL volume.
Sponsors
KOBAYASHI Pharmaceutical Co.,Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy men and women aged 20 to 65. 2) Individuals of Japanese nationality. 3) Employees of Kobayashi Pharmaceutical Co., Ltd. 4) Individuals who have understood the purpose and procedures of this study and have voluntarily provided written informed consent to participate.
Exclusion criteria
Exclusion criteria: 1) Individuals with an aversion to the flavor of test products. 2) Current smokers or those who have quit smoking for less than 6 months. 3) Individuals with a habit of excessive alcohol consumption (defined as a daily pure alcohol intake of 40g or more for men, and 20g or more for women). 4) Individuals currently using any medications, quasi-drugs, health foods, supplements, or Foods with Function Claims (e.g., GABA, L-theanine) purported to have stress-reducing or relaxing effects. 5) Individuals who plan significant changes to their lifestyle (e.g., diet, sleep, exercise habits), including long-term travel, during the study period. 6) Individuals taking any medication on a continuous basis for therapeutic purposes. 7) Individuals with nasal congestion (e.g., due to allergic rhinitis) or those unable to perceive or judge aromas. 8) Individuals with a history of or current serious disease of the heart, liver, kidneys, or digestive system. 9) Individuals with injuries on their forehead or left index finger. 10) Women who are pregnant, lactating, or planning to become pregnant. 11) Individuals currently participating in another clinical study or who have completed participation within one month prior to the start of this study. 12) Individuals with self-reported physical discomfort due to low atmospheric pressure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brain waves | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Heart Rate Variability (HRV) parameters Visual analogue scale Likert scale | — |
Countries
Japan
Contacts
Public ContactMasaya Tsujikami
KOBAYASHI Pharmaceutical Co., Ltd. Life Science Research Department R&D Headquarters
Outcome results
None listed